A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
6.50 +0.00 (0.00%) PLX

Click Here to Receive Instant E-mail and RSS Alerts


Trade PLX now with

Stock Details

Last Trade:6.50 Change:+0.00 (0.00%) Prev Close:6.50 Open: 6.60 Days Range:6.37 – 6.64 52 Week Range: 4.06 - 9.90 Volume:241152 P/E: 72.22
EPS:0.09





Recent Blog Posts

Blog Posts on 02/08/12 at 11:46am
Medgenics' Disruptive Biotechnology Is One To Watch
Blog Posts on 01/27/12 at 10:17am
Another Catalyst For Protalix BioTherapeutics
Blog Posts on 01/12/12 at 5:11am
Pharma And Biotechs With FDA Drug Approval Decisions In Q2 2012
Blog Posts on 12/07/11 at 9:17am
Protalix BioTherapeutics: FDA Delay Provides Attractive Entry Point
Blog Posts on 09/15/11 at 4:02pm
Protalix Biotherapeutics: Using Plants To Treat Human Disease
Blog Posts on 09/04/11 at 4:02am
Protalix BioTherapeutics: Near-Term Catalysts With Big Upside Potential
Blog Posts on 07/19/11 at 10:17am
A Follow-Up: How My '11 Stock Picks for 2011' Are Performing
Blog Posts on 05/16/11 at 10:18am
Biotech: Some CRL Recipients to Consider
Blog Posts on 05/16/11 at 10:17am
Top Picks by Biotech and Medical Device Focused Hedge Fund DAFNA Capital Management
Blog Posts on 04/07/11 at 12:34pm
Biotech: Top 3 Analyst Picks
Blog Posts on 04/04/11 at 9:07am
14 Small Caps With 2 or More Analyst Downgrades in March
Blog Posts on 03/23/11 at 1:50pm
5 Stocks Near Lows Seeing Significant Short Covering
Blog Posts on 03/01/11 at 4:50am
Niche Opportunity May Be Slipping From Protalix's Grasp
Blog Posts on 03/01/11 at 1:35am
Top 30 Most Undervalued, Underperforming Stocks
Blog Posts on 02/28/11 at 11:33am
The Prospects for Protalix Still Look Pretty Good
Blog Posts on 02/28/11 at 10:46am
22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12
Blog Posts on 02/27/11 at 9:46am
What's Next for Protalix BioTherapeutics Shares Fall After FDA CRL?
Blog Posts on 02/24/11 at 11:40am
A Safe Strategy to Play Protalix
Blog Posts on 02/23/11 at 4:03am
4 Israeli Firms Headed to $1 Billion
Blog Posts on 02/18/11 at 1:28pm
Conservative, Bullish Trading Strategy on Protalix Biotherapeutics' PDUFA Date
Blog Posts on 02/14/11 at 2:52pm
UBS Analyst Misses Boat With Protalix Comments
Blog Posts on 02/11/11 at 3:02pm
iBio: Risky, But Early Stage Pipeline Potentially Offers Long-Term Reward
Blog Posts on 02/09/11 at 8:36am
iBio Overvalued
Blog Posts on 02/08/11 at 4:56pm
Maximizing Opportunity and Minimizing Risk With Trading FDA Decisions
Blog Posts on 02/02/11 at 1:33pm
Insider Selling and Options Trading May Spell Troubles for Protalix
Blog Posts on 02/02/11 at 10:42am
FDA Catalyst Trade: Protalix BioTherapeutics
Blog Posts on 01/24/11 at 9:26am
iBio: A True Paradigm Shift
Blog Posts on 01/20/11 at 10:01am
Protalix BioTherapeutics: Recent Dip Represents Attractive Entry Point
Blog Posts on 01/18/11 at 7:19am
Contrarian Ideas: 20 Healthcare Stocks With Low Put/Call Ratios
Blog Posts on 01/17/11 at 8:07am
11 Stock Picks for 2011: My Top (Relatively Safe) Holdings